|Day Low/High||1.50 / 1.57|
|52 Wk Low/High||1.04 / 1.65|
Previously studies already showed improvement from use of Exelixis's Cabometyx over Pfizer's Sutent in treating kidney cancer patients.
Investors in Pluristem Therapeutics Inc saw new options begin trading this week, for the December 15th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 225 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Stocks turn mixed on Tuesday, though the Nasdaq remains on track to set to record a close for its third day in a row.
Stocks turn higher Tuesday as crude oil declines and the fourth-quarter earnings season draws closer.
Stock futures are little changed on Tuesday as investors await news from a press conference Wednesday with President-elect Donald Trump. Oil prices level off.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.